The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse

Prafullakumar Tailor1, Tomohiko Tamura, Herbert C Morse

  • 1Laboratory of Molecular Growth Regulation, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-2753, USA.

Blood
|December 7, 2007
PubMed
Summary

A mutation in interferon regulatory factor 8 (IRF8) impairs CD8alpha(+) dendritic cell (DC) development and IL12 production but not plasmacytoid DC (pDC) function. This reveals distinct roles for IRF8 in DC subset development.

Related Concept Videos